VVIX Signals Trouble Ahead Amid Retail Rout, Bond-Buying, & Gold Gains
Ignore the rout in retail, focus on FANG… and hope for some dovish cooing from Yellen… Expectations for higher VIX uncertainty (VVIX – VIX of VIX) are at their highest relative to VIX since Dec 2006… h/t @Schuldensuehner Which just happened to mark the beginning of the end of the great moderation and the start of chaos […]
The Case-Shiller Home Price Indices – How Cities Have Recovered Since The Housing Crisis
We discuss some of the Methodology of the Case-Shiller Home Price Index in this Housing Market video, and then go over 20 cities and compare and contrast how each has fared since the Housing Market Crash. Seattle, Portland, Dallas and Denver are some really hot Housing Markets. Las Vegas still has a long way to […]
EC The Pros And Cons Of The Dividend Discount Model
There has been much said about investing and how to accurately value a particular stock or other asset. Plenty of theories exist as to how to determine the real value of an investment today. There are few models as popular as the dividend discount model (DDM) though, and this alone warrants a review of the pros and […]
The Bernanke-Yellen Bubble-Depression
In a recent article I advocated for a new way of naming business cycles. The new approach emphasizes the cause rather than the effect. So instead of the “housing bubble” and “financial crisis,” we should refer to the Greenspan-Bernanke Crisis. Here we will turn our attention to the current situation. The current economy is a […]
Stocks And Precious Metals Chart – Me And My Baby
“Learn what is to be taken seriously and laugh at the rest.” Hermann Hesse “Narcissism falls along the axis of what psychologists call personality disorders, one of a group that includes antisocial, dependent, histrionic, avoidant and borderline personalities. But by most measures, narcissism is one of the worst, if only because the narcissists themselves are […]
Celgene Potentially Worth $200 Per Share, Says Analyst
Shares of biotech giant Celgene (CELG) may be worth $200 per share if peak sales of late-stage assets, including luspatercept, ozanimod, and GED301 are met, said analyst Ying Huang. LUSPATERCEPT: Luspatercept is an experimental drug in clinical trials for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. It is being developed by Acceleron […]
What’s The Safest Investment In Troubled Times?
What’s the safest investment as the global economy enters increasingly risky, troubled times? I’ve reviewed hundreds of academic papers, investment reports and newsletters and researched long-term strategies and backtests and reached one conclusion. I won’t keep you in suspense: it’s bat guano (or seabird guano if you can’t get the bat stuff). Yes, bat doo-doo is the […]
No Luck China, Either
Former IMF chief economist Ken Rogoff warned today on CNBC that he was concerned about China. Specifically, he worried that country might “export a recession” to the rest of Asia if not the rest of the world. I’m not sure if he has been paying attention or not, but the Chinese economy since 2012 has been doing just that […]
